Le Lézard
Classified in: Health
Subjects: AWD, DEI, ESG

BD Named to Forbes' 2022 List of Best Employers for Diversity


Demonstrates Progress in Advancing 2030+ ESG Goals

FRANKLIN LAKES, N.J., April 26, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been recognized by Forbes as one of the top employers in the U.S. for diversity.

The list is compiled by surveying more than 60,000 Americans who work for companies with at least 1,000 employees to identify organizations that are the most committed to diversity, equity and inclusion. The evaluation was based on the following criteria:

"It's an honor to receive this recognition and it's a testament to the progress we're making in fostering an inclusive environment where BD associates can be their authentic selves, feel comfortable speaking up, have an equitable opportunity to grow and develop in their careers, and ultimately share their best and most innovative thinking," said Nicole Thompson, vice president of HR ? Inclusion, Diversity, Equity & Engagement at BD. "An inclusive environment, coupled with a diverse workforce, produces better products and better outcomes, contributing to the health of our company, planet and communities."

This recognition demonstrates the company's ongoing progress in advancing its environmental, social and governance (ESG) strategy, and efforts to achieve its 2030+ goals for promoting a healthy workforce and communities. These goals encompass maintaining a healthy and thriving workforce that cultivates the company's culture of inclusion, safety, well-being, and also contributes to community and company health. In addition to this accolade, BD recently celebrated the following recognitions:

To learn more about the inclusion, diversity and equity systems, processes and tools that drive action and accountability at BD, read the 2021 Global ID&E Report.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

Contacts:               




Media:                     

Investors:

Troy Kirkpatrick             

Francesca DeMartino

VP, Public Relations           

SVP, Head of Investor Relations

858.617.2361                     

201.847.5743        

[email protected]     

[email protected]

   

SOURCE BD (Becton, Dickinson and Company)


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....



News published on and distributed by: